Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 156,915 | 133,512 | 117,975 | 106,354 | 106,728 |
| Receivables | 120,080 | 120,454 | 127,138 | 130,519 | 115,107 |
| Inventories | 127,885 | 131,555 | 122,032 | 122,384 | 110,425 |
| Income taxes - deferred | 26,203 | 24,902 | 23,433 | 22,872 | 25,188 |
| Other current assets | 29,508 | 19,488 | 19,974 | 16,240 | 18,890 |
| TOTAL | $460,591 | $429,911 | $410,552 | $398,369 | $376,338 |
| Non-Current Assets | |||||
| PPE Net | 201,725 | 200,610 | 196,714 | 197,063 | 199,946 |
| Intangibles | 55,752 | 57,554 | 57,873 | 61,304 | 212,612 |
| Other Non-Current Assets | 179,076 | 174,222 | 168,596 | 167,548 | 19,631 |
| TOTAL | $436,553 | $432,386 | $423,183 | $425,915 | $432,189 |
| Total Assets | $897,144 | $862,297 | $833,735 | $824,284 | $808,527 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 863 | 850 | 838 | 825 | 813 |
| Accounts payable and accrued liabilities | 22,669 | 25,273 | 23,190 | 24,104 | 19,133 |
| Accrued Expenses | 118,598 | 108,184 | 99,629 | 94,616 | 104,959 |
| TOTAL | $285,112 | $270,933 | $271,200 | $289,167 | $256,305 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,418 | 3,639 | 3,856 | 4,070 | 4,281 |
| Deferred Revenues | 13,983 | 10,714 | 13,681 | 12,234 | 12,610 |
| Other Non-Current Liabilities | 11,036 | 12,405 | 11,718 | 11,697 | 11,266 |
| TOTAL | $37,751 | $44,712 | $38,258 | $37,985 | $37,643 |
| Total Liabilities | $322,863 | $315,645 | $309,458 | $327,152 | $293,948 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 114,671 | 115,008 | 115,412 | 115,304 | 116,123 |
| Common Shares | 9,797 | 9,762 | 9,729 | 9,679 | 9,633 |
| Retained earnings | 965,540 | 929,169 | 894,475 | 857,282 | 824,256 |
| Other shareholders' equity | 18,299 | 16,200 | 7,657 | 11,247 | 14,893 |
| TOTAL | $574,281 | $546,652 | $524,277 | $497,132 | $514,579 |
| Total Liabilities And Equity | $897,144 | $862,297 | $833,735 | $824,284 | $808,527 |